Cart
sales@molnova.com
CK2-IN-1 B
CAS No. 51726-83-1
CK2-IN-1 B( —— )
Catalog No. M33895 CAS No. 51726-83-1
CK2 inhibitor
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 32 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 131 | In Stock |
|
| 50MG | 193 | In Stock |
|
| 100MG | 280 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCK2-IN-1 B
-
NoteResearch use only, not for human use.
-
Brief DescriptionCK2 inhibitor
-
DescriptionCK2-IN-1 is a CK2 inhibitor, with an IC50 of 150 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number51726-83-1
-
Formula Weight239.23
-
Molecular FormulaC14H9NO3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOC(=O)c1c[nH]c2c3ccccc3ccc2c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Sanela Marti?, et al. Electrochemical screening of the indole/quinolone derivatives as potential protein kinase CK2 inhibitors. Anal Biochem. 2012 Feb 15;421(2):617-21.?
molnova catalog
related products
-
Anthraflavic acid
Anthraflavic acid a flavonoid is a potent IQ mutagenicity and cytochrome P-448?inhibitor.
-
Remimazolam
Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?
-
Eubulus-A80
Eubulus-A80 is a anti-tumor agent (WO2021/183702, Compound A80).
